You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -359.3% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.9 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 12.9 | n/a |
| Price / Book value | 1.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 20.1% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.96 | -1.05 | -12.71p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 1.15 | -4.14 | -8.05p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| GENinCode prepares for US revenue as California licence granted Sharecast News | 03 Jan |
|---|---|
| GENinCode inks collaboration with largest US medical school Sharecast News | 23 Mar |
| GENinCode enters cholesterol collaboration with Cumbria health network Sharecast News | 15 Mar |
| Second Price Monitoring Extn | 03-Jan-23 23:58 |
|---|---|
| Price Monitoring Extension | 03-Jan-23 23:58 |
| Approval of California state license | 03-Jan-23 14:36 |
| Issue of Share Options | 22-Nov-22 23:20 |
| British Medical Journal publication | 03-Nov-22 14:37 |